SRAX Stock Forecast, Price & News

+0.03 (+0.60 %)
(As of 06/22/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume408,519 shs
Average Volume814,195 shs
Market Capitalization$117.55 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive SRAX News and Ratings via Email

Sign-up to receive the latest news and ratings for SRAX and its competitors with MarketBeat's FREE daily newsletter.

SRAX logo

About SRAX

SRAX, Inc., a technology company, focused on enhancing communications between public companies and their shareholders and investors in the United States. The company offers Sequire, a Saas platform that allows issuers to track their shareholders' behaviors and trends, then use data-driven insights to engage with shareholders across marketing channels. It also organizes and hosts investor conferences within the micro and small- cap space. The company markets and sells its services through its in-house sales and marketing team. The company was formerly known as Social Reality, Inc. and changed its name to SRAX, Inc. in August 2019. SRAX, Inc. was founded in 2009 and is headquartered in Westlake Village, California.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.33 out of 5 stars

Business Services Sector

190th out of 505 stocks

Advertising Agencies Industry

5th out of 18 stocks

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

SRAX (NASDAQ:SRAX) Frequently Asked Questions

Is SRAX a buy right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for SRAX in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" SRAX stock.
View analyst ratings for SRAX
or view top-rated stocks.

What stocks does MarketBeat like better than SRAX?

Wall Street analysts have given SRAX a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but SRAX wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting SRAX?

SRAX saw a decrease in short interest during the month of May. As of May 28th, there was short interest totaling 687,800 shares, a decrease of 35.1% from the May 13th total of 1,060,000 shares. Based on an average daily trading volume, of 718,300 shares, the short-interest ratio is currently 1.0 days. Currently, 3.4% of the shares of the stock are sold short.
View SRAX's Short Interest

When is SRAX's next earnings date?

SRAX is scheduled to release its next quarterly earnings announcement on Monday, August 16th 2021.
View our earnings forecast for SRAX

How were SRAX's earnings last quarter?

SRAX, Inc. (NASDAQ:SRAX) released its quarterly earnings results on Monday, May, 24th. The business services provider reported ($0.57) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.13) by $0.44. The business services provider had revenue of $5.44 million for the quarter, compared to analyst estimates of $5.03 million. SRAX had a negative trailing twelve-month return on equity of 84.63% and a negative net margin of 165.90%.
View SRAX's earnings history

How has SRAX's stock price been impacted by COVID-19?

SRAX's stock was trading at $2.52 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, SRAX stock has increased by 101.2% and is now trading at $5.07.
View which stocks have been most impacted by COVID-19

What guidance has SRAX issued on next quarter's earnings?

SRAX updated its FY 2021 earnings guidance on Tuesday, June, 15th. The company provided earnings per share guidance of $- for the period. The company issued revenue guidance of $25 million-27 million, compared to the consensus revenue estimate of $25.90 million.

What price target have analysts set for SRAX?

3 brokerages have issued 12-month price targets for SRAX's shares. Their forecasts range from $7.00 to $10.00. On average, they anticipate SRAX's stock price to reach $8.17 in the next year. This suggests a possible upside of 61.1% from the stock's current price.
View analysts' price targets for SRAX
or view top-rated stocks among Wall Street analysts.

Who are SRAX's key executives?

SRAX's management team includes the following people:
  • Mr. Christopher Miglino, Co-Founder, Chairman, CEO & Pres (Age 52, Pay $431.03k)
  • Mr. Michael Thomas Malone, Chief Financial Officer (Age 39, Pay $296.55k)
  • Mr. Christopher Lahiji, Director & Pres of LD Micro, Inc. (Age 37, Pay $207.88k)
  • Mr. Randy Clark, C.O.O.
  • Mr. Taewook Kang, Chief Technology Officer
  • Mr. Aam Johnson, VP of Sales
  • Mr. Vladi Delsoglio, Chief Creative Officer
  • Ms. Kathy Ireland, Chief Branding Advisor
  • Mr. Moises Avitia, Pres of Latam
  • Rick McCrady, VP of Research Sales

Who are some of SRAX's key competitors?

What other stocks do shareholders of SRAX own?

Based on aggregate information from My MarketBeat watchlists, some companies that other SRAX investors own include TG Therapeutics (TGTX), Zynerba Pharmaceuticals (ZYNE), Lowe's Companies (LOW), Square (SQ), Skyworks Solutions (SWKS), TransEnterix (TRXC), Tesla (TSLA), Vuzix (VUZI), Wells Fargo & Company (WFC) and Advanced Micro Devices (AMD).

What is SRAX's stock symbol?

SRAX trades on the NASDAQ under the ticker symbol "SRAX."

Who are SRAX's major shareholders?

SRAX's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Intrinsic Edge Capital Management LLC (3.13%), Renaissance Technologies LLC (0.94%), Geode Capital Management LLC (0.51%), Dimensional Fund Advisors LP (0.37%), PEAK6 Investments LLC (0.30%) and NorthRock Partners LLC (0.22%).
View institutional ownership trends for SRAX

Which major investors are selling SRAX stock?

SRAX stock was sold by a variety of institutional investors in the last quarter, including Kestra Advisory Services LLC.
View insider buying and selling activity for SRAX
or view top insider-selling stocks.

Which major investors are buying SRAX stock?

SRAX stock was bought by a variety of institutional investors in the last quarter, including Intrinsic Edge Capital Management LLC, Renaissance Technologies LLC, PEAK6 Investments LLC, NorthRock Partners LLC, Geode Capital Management LLC, Dimensional Fund Advisors LP, Alpha Paradigm Partners LLC, and Bank of New York Mellon Corp.
View insider buying and selling activity for SRAX
or or view top insider-buying stocks.

How do I buy shares of SRAX?

Shares of SRAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is SRAX's stock price today?

One share of SRAX stock can currently be purchased for approximately $5.07.

How much money does SRAX make?

SRAX has a market capitalization of $117.55 million and generates $14.65 million in revenue each year. The business services provider earns $-14,700,000.00 in net income (profit) each year or ($0.84) on an earnings per share basis.

How many employees does SRAX have?

SRAX employs 153 workers across the globe.

What is SRAX's official website?

The official website for SRAX is

Where are SRAX's headquarters?

SRAX is headquartered at 456 SEATON STREET, LOS ANGELES CA, 90013.

How can I contact SRAX?

SRAX's mailing address is 456 SEATON STREET, LOS ANGELES CA, 90013. The business services provider can be reached via phone at 323-694-9800 or via email at [email protected]

This page was last updated on 6/23/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.